Not a medicine and not authorised for human use in the UK
Increased growth hormone levels can support lean muscle growth, improved fat metabolism, faster recovery from exercise or injury, better sleep quality, and enhanced skin elasticity
Beneficiaries who were coded with obesity or overweight and either a prior heart attack (AMI_EVER), prior stroke (STROKE_TIA_EVER), or peripheral arterial disease were coded as being eligible for the new use of Wegovy
Resistance mechanisms to Anti-PD cancer immunotherapy
US Food and Drug Administration (FDA) Approvals of GLP-1 and GLP1/GIP RAs 11,22-34 However, these labels are being expanded to include additional indications for patients with a spectrum of other cardiometabolic conditions, such as obesity, cardiovascular disease, chronic kidney disease, and obstructive sleep apnea